author-photo

John P. Pribble

Memorial Hospital of Rhode Island

23

Papers

3712

Citations

Citation Trend

Filter By

Papers (23) Sort By

Journal Conference Others

Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis.

2007 Critical Care Medicine
Show All
- Source
- Cite
- Save
Citations (43)
Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis.

2005 Shock
Show All
- Source
- Cite
- Save
Citations (200)
CD14 receptor occupancy in severe sepsis: Results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14)*

2004 Critical Care Medicine
Show All
- Source
- Cite
- Save
Citations (59)
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

2004 Critical Care Medicine
Show All
- Source
- Cite
- Save
Citations (137)
AUGMENTATION OF APACHE II AND MOD SCORES BY PLASMA CYTOKINE CONCENTRATIONS AS INDICATORS OF OUTCOME IN SEPSIS: 394

2004 Shock
Show All
- Source
- Cite
- Save
Citations (1)
Effect of IC14, an anti‐CD14 antibody, on plasma and cell‐associated chemokines during human endotoxemia

2003 European Cytokine Network
Show All
- Source
- Cite
- Save
Citations (12)
Effect of IC14, an anti-CD14 antibody, on plasma and cell-associated chemokines during human endotoxemia

2003 Carcinogenesis
Show All
- Source
- Cite
- Save
Citations (0)
Effects of IC14, an Anti‐CD14 Antibody, on Coagulation and Fibrinolysis during Low‐Grade Endotoxemia in Humans

2003 Carcinogenesis
Show All
- Source
- Cite
- Save
Citations (0)
Treatment with an Anti-CD14 Monoclonal Antibody Delays and Inhibits Lipopolysaccharide-Induced Gene Expression in Humans in Vivo

2003 Carcinogenesis
Show All
- Source
- Cite
- Save
Citations (0)
Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial.

2003 Critical Care Medicine
Show All
- Source
- Cite
- Save
Citations (74)